thioctic acid has been researched along with Dry Macular Degeneration in 1 studies
Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kim, BJ | 1 |
Hunter, A | 1 |
Brucker, AJ | 1 |
Hahn, P | 1 |
Gehrs, K | 1 |
Patel, A | 1 |
Edwards, AO | 1 |
Li, Y | 1 |
Khurana, RN | 1 |
Nissim, I | 1 |
Daniel, E | 1 |
Grunwald, J | 1 |
Ying, GS | 1 |
Pistilli, M | 1 |
Maguire, MG | 1 |
Dunaief, JL | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effect of Alpha-Lipoic Acid on the Clinical Outcome of Patients With Sepsis[NCT05808946] | Phase 2/Phase 3 | 60 participants (Anticipated) | Interventional | 2023-03-10 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for thioctic acid and Dry Macular Degeneration
Article | Year |
---|---|
Orally Administered Alpha Lipoic Acid as a Treatment for Geographic Atrophy: A Randomized Clinical Trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antioxidants; Dose-Response Relationship, Drug; Doubl | 2020 |